BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4 AND Clinical Outcome
213 results:

  • 1. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
    Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
    Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature.
    Kritikos M; Vivanco-Suarez J; Teferi N; Lee S; Kato K; Eschbacher KL; Bathla G; Buatti JM; Hitchon PW
    Neurosurg Rev; 2024 Feb; 47(1):75. PubMed ID: 38319484
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Automated localization and segmentation of cervical lymph nodes on contrast-enhanced CT using a 3D foveal fully convolutional neural network.
    Rinneburger M; Carolus H; Iuga AI; Weisthoff M; Lennartz S; Hokamp NG; Caldeira L; Shahzad R; Maintz D; Laqua FC; Baeßler B; Klinder T; Persigehl T
    Eur Radiol Exp; 2023 Jul; 7(1):45. PubMed ID: 37505296
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients.
    Bolaños-Suárez V; Alfaro A; Espinosa AM; Medina-Martínez I; Juárez E; Villegas-Sepúlveda N; Gudiño-Zayas M; Gutiérrez-Castro A; Román-Bassaure E; Salinas-Nieves ME; Bruno-Muñoz S; Aranda C; Flores-Herrera O; Berumen J
    Cancer Med; 2023 Jul; 12(14):15632-15649. PubMed ID: 37326348
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study.
    Song S; Han D; Zhang N; Mao Z; Guo X; Cheng G
    Radiat Oncol; 2023 Mar; 18(1):46. PubMed ID: 36879287
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diffusion basis spectrum imaging predicts long-term clinical outcomes following surgery in cervical spondylotic myelopathy.
    Zhang JK; Jayasekera D; Javeed S; Greenberg JK; Blum J; Dibble CF; Sun P; Song SK; Ray WZ
    Spine J; 2023 Apr; 23(4):504-512. PubMed ID: 36509379
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. clinical outcome and Risk Factors of Chronic Radiation Proctitis Following Pelvic Radiation Therapy.
    Im CM; Cho IJ; Yu HJ; Han B; Oh HH; Seo YJ; Kim KH; Myung DS; Cho SB; Lee WS; Nam TK; Joo YE
    Anticancer Res; 2022 Dec; 42(12):5951-5959. PubMed ID: 36456158
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: clinical outcome and prognostic factors.
    Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
    Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose.
    Kok HP; Herrera TD; Crezee J
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):994-1003. PubMed ID: 36288756
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
    Rogowski P; Rottler M; Walter F; Saicic S; Niyazi M; Well J; Nierer L; Trillsch F; Burges A; Mahner S; Belka C; Corradini S
    Gynecol Oncol; 2022 Sep; 166(3):576-581. PubMed ID: 35764443
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
    Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
    J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Influence of Grading on Management and outcome in Mucoepidermoid Carcinoma of the Parotid-A Multi-institutional Analysis.
    Grasl S; Janik S; Faisal M; Grasl MC; Pammer J; Weinreb I; Fischer G; Kim J; Hosni A; de Almeida JR; Goldstein DP; Erovic BM
    Laryngoscope; 2023 Jan; 133(1):124-132. PubMed ID: 35475580
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: A single-institution experience.
    Kim MS; Jeong SY; Lee YY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Taiwan J Obstet Gynecol; 2022 Mar; 61(2):333-338. PubMed ID: 35361397
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
    Zeng J; Sun P; Ping Q; Jiang S; Hu Y
    PLoS One; 2022; 17(3):e0266001. PubMed ID: 35324998
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy.
    Javed S; Sood S; Rai B; Bhattacharyya S; Bagga R; Srinivasan R
    Indian J Med Res; 2021 Aug; 154(2):367-374. PubMed ID: 35295009
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effects of steroid use for stenosis prevention after endoscopic submucosal dissection for cervical esophageal cancer.
    Muroi K; Kakushima N; Furukawa K; Furune S; Ito N; Hirose T; Ishikawa E; Mizutani Y; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Funasaka K; Miyahara R; Fujishiro M
    Int J Clin Oncol; 2022 May; 27(5):940-947. PubMed ID: 35194703
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Magnetic Resonance Imaging-Guided Adaptive Brachytherapy for the Treatment of cervical cancer and its Impact on clinical outcome.
    Singhal S; Veeratterapillay J; Locks S; Morgan D; Patil R; Chamberlain HM
    Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):442-451. PubMed ID: 35123850
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Preoperative high-dose-rate brachytherapy for high-risk early-stage cervical cancer: Long-term clinical outcome analysis.
    Gauci PA; Kee DLC; Thamphya B; Schiappa R; Delotte J; Chand-Fouche ME; Hannoun-Levi JM
    Brachytherapy; 2022; 21(3):273-282. PubMed ID: 35094933
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Impact of Histological Subtype on Survival outcome of Patients with Stage IIB-IVA cervical cancer Who Received Definitive Radiotherapy.
    Miyahara S; Tsuji K; Shimada M; Shibuya Y; Shigeta S; Nagai T; Umezawa R; Tokunaga H; Jingu K; Yaegashi N
    Tohoku J Exp Med; 2021 Dec; 255(4):303-313. PubMed ID: 34911878
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. clinical results of image-guided interstitial brachytherapy with or without external beam radiotherapy for postsurgical vaginal recurrence of cervical and endometrial cancers.
    Kanemoto A; Sugita T; Ayukawa F; Takahashi K; Horiuchi A; Haino K; Kikuchi A
    Jpn J Radiol; 2022 Jun; 40(6):639-644. PubMed ID: 34851502
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.